Rabbit Anti-Human IGF-Binding Protein 6, IgG Fraction, Polyclonal
1mg
$425.00
Skip to product information
Rabbit Anti-Human IGF-Binding Protein 6, IgG Fraction, Polyclonal
Catalog no.
PB-383-9
$425.00
Anti-human IGF-Binding protein 6 IgG fraction is a polyclonal antibody raised in rabbit against purified human recombinant IGF-binding Protein 6. It is purified using Protein G.
- Storage: Store at -20°C.
- Stability: At least 1 year at -20°C.
- Biological activity: This polyclonal antibody recognizes human IGFBP-6, having a minor cross-reactivity with IGFBP-5 on a Western assay using a 1/100 dilution.
- Formulation: IgG fraction. Frozen liquid. 1.0 mg/mL. Formulated in 0.1 M Tris-HCl (pH 7.5)
Publications using Austral Biologicals PB-383
The following scientific publications report use of the anti-IGFBP-6 polyclonal antibody from Austral Biologicals:
- IGF-II and IGFBP-6 regulate cellular contractility and proliferation in Dupuytren's disease. Raykha et al., Biochimica et Biophysica Acta - Molecular Basis of Disease 1832(10):1511-1519 (2013).
- Expression of the insulin-like growth factor and insulin systems in the luteinizing macaque ovarian follicle. Brogan et al., Fertility and Sterility 93(5):1421-1429 (2010).
- Rexinoid-induced expression of IGFBP-6 requires RARbeta-dependent permissive cooperation of retinoid receptors and AP-1. Uray et al., Journal of Biological Chemistry 284(1):345-353 (2009).
- Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer. Koike et al., British Journal of Cancer 92(8):1538-1544 (2005).
- The IGF system in neuroblastoma xenografts: focus on IGF-binding protein-6. Grellier et al., Journal of Endocrinology 172(3):467-476 (2002).
- Coordinated control of fetal gastric epithelial functions by insulin-like growth factors and their binding proteins. Tremblay et al., Endocrinology 142(5):1795-1803 (2001).
- Insulin-like growth factor binding protein-6 inhibits the growth of human bronchial epithelial cells and increases in abundance with all-trans-retinoic acid treatment. Sueoka et al., American Journal of Respiratory Cell and Molecular Biology 23(3):297-303 (2000).
- Insulin-like growth factor binding proteins-2 to -6 are expressed by human vascular smooth muscle cells. Andersson et al., Journal of Endocrinology 163(2):281-288 (1999).
- N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line. Chambéry et al., Cancer Research 59(12):2898-2902 (1999).
- Regulation of IGF binding protein synthesis by a bovine mammary epithelial cell line. Cohick and Turner, Journal of Endocrinology 157(2):327-336 (1998).
- Modulation of insulin-like growth factor (IGF) and IGF binding protein biosynthesis by hypoxia in cultured vascular endothelial cells. Tucci et al., Journal of Endocrinology 157(1):13-24 (1998).
- Insulin-like growth factor system in bovine first-wave dominant and subordinate follicles. de la Sota et al., Biology of Reproduction 55(4):803-812 (1996).